Pan-cancer analysis of ARID1A Alterations as Biomarkers for Immunotherapy Outcomes

ARID1A alterations would compromise mismatch repair pathway and increase the number of tumor-infiltrating lymphocytes and PD-L1 expression in some cancers, which would cooperate with immune checkpoint inhibitors (ICIs) treatment. However, a comprehensive analysis of ARID1A alteration frequency and i...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiang, Tao, Chen, Xiaoxia, Su, Chunxia, Ren, Shengxiang, Zhou, Caicun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2020
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6959029/
https://www.ncbi.nlm.nih.gov/pubmed/31949479
http://dx.doi.org/10.7150/jca.41296

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6959029/
https://www.ncbi.nlm.nih.gov/pubmed/31949479
http://dx.doi.org/10.7150/jca.41296

Ejemplares similares